Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial

This study has been completed.

Sponsor:

Collaborators:

The 4C trial bureau

Japan Heart Foundation

Information provided by (Responsible Party):

Hisao Ogawa, Kumamoto University

ClinicalTrials.gov Identifier:

NCT00139386

First received: August 29, 2005

Last updated: April 17, 2013

Last verified: April 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2012
Primary Completion Date:	April 2009 (Final data collection date for primary outcome measure)